Price
Financials
Standalone, Rs crore| Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.20 | 0.25 | 0.18 | 0.23 | 0.40 | 0.20 | 0.21 | 0.22 | 0.19 | 0.21 | 0.35 | 0.20 |
| Expenses | 7.41 | 0.19 | 0.13 | 0.18 | 0.24 | 0.13 | 0.15 | 0.13 | 0.14 | 0.17 | 0.32 | 0.17 |
| Operating Profit | -0.21 | 0.06 | 0.05 | 0.05 | 0.16 | 0.07 | 0.06 | 0.09 | 0.05 | 0.04 | 0.03 | 0.03 |
| OPM % | -2.92% | 24.00% | 27.78% | 21.74% | 40.00% | 35.00% | 28.57% | 40.91% | 26.32% | 19.05% | 8.57% | 15.00% |
| Other Income | 0.03 | 0.03 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.05 | 0.04 | 0.04 | 0.04 | 0.15 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
| Profit before tax | -0.23 | 0.05 | 0.03 | 0.04 | 0.01 | 0.03 | 0.02 | 0.05 | 0.01 | 0.01 | 0.00 | 0.00 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Net Profit | -0.24 | 0.04 | 0.03 | 0.04 | 0.01 | 0.04 | 0.02 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS in Rs | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.58 | 47.41 | 55.99 | 45.56 | 45.83 | 0.82 | 1.06 | 0.83 | 0.96 | 0.18 | 0.00 | 0.00 |
| Expenses | 20.25 | 43.78 | 54.78 | 44.49 | 44.89 | 0.64 | 0.74 | 0.56 | 0.83 | 0.43 | 2.22 | 0.39 |
| Operating Profit | 1.33 | 3.63 | 1.21 | 1.07 | 0.94 | 0.18 | 0.32 | 0.27 | 0.13 | -0.25 | -2.22 | -0.39 |
| OPM % | 6.16% | 7.66% | 2.16% | 2.35% | 2.05% | 21.95% | 30.19% | 32.53% | 13.54% | -138.89% | ||
| Other Income | 0.10 | 0.10 | 0.13 | 0.11 | 0.09 | 0.11 | 0.08 | 0.00 | 1.22 | -1.87 | -1.22 | -0.44 |
| Interest | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.47 | 0.37 | 0.41 | 0.37 | 0.28 | 0.22 | 0.28 | 0.15 | 0.10 | 0.07 | 0.02 | 0.01 |
| Profit before tax | 0.96 | 3.36 | 0.92 | 0.81 | 0.75 | 0.07 | 0.12 | 0.12 | 1.25 | -2.19 | -3.46 | -0.84 |
| Tax % | 38.54% | 2.08% | 0.00% | 13.58% | 4.00% | 14.29% | 0.00% | 33.33% | 10.40% | -0.46% | -1.73% | 0.00% |
| Net Profit | 0.59 | 3.29 | 0.92 | 0.70 | 0.71 | 0.07 | 0.13 | 0.08 | 1.12 | -2.18 | -3.40 | -0.84 |
| EPS in Rs | 0.05 | 0.30 | 0.08 | 0.06 | 0.06 | 0.01 | 0.01 | 0.01 | 0.10 | -0.20 | -0.31 | -0.08 |
| Dividend Payout % | 55.88% | 30.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | % | ||
| Compounded Profit Growth | % | % | % | 82% | ||
| Stock Price CAGR | -5% | % | % | % | ||
| Return on Equity | 1% | -3% | -11% | -6% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
| Reserves | 3.60 | 5.73 | 6.65 | 7.35 | 8.05 | 8.12 | 8.15 | 8.23 | 1.10 | -1.07 | -4.47 | -5.31 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.79 | 1.70 | 0.41 | 0.45 | 0.39 | 0.30 | 0.31 | 0.34 | 0.32 | 0.19 | 1.02 | 0.29 |
| Total Liabilities | 15.38 | 18.42 | 18.05 | 18.79 | 19.43 | 19.41 | 19.45 | 19.56 | 12.41 | 10.11 | 7.54 | 5.97 |
| Fixed Assets | 5.13 | 5.00 | 5.29 | 5.24 | 4.96 | 4.74 | 4.37 | 4.22 | 4.12 | 3.95 | 3.75 | 3.74 |
| CWIP | 0.58 | 1.24 | 1.32 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.17 | 0.25 | 0.25 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 1.67 | 1.60 | 1.60 | 1.60 |
| Other Assets | 9.50 | 11.93 | 11.19 | 11.69 | 12.61 | 12.81 | 13.22 | 13.48 | 6.62 | 4.56 | 2.19 | 0.63 |
| Total Assets | 15.38 | 18.42 | 18.05 | 18.79 | 19.43 | 19.41 | 19.45 | 19.56 | 12.41 | 10.11 | 7.54 | 5.97 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1.16 | 1.02 | 0.74 | 0.42 | -0.07 | -0.01 | -0.11 | 0.04 | -0.10 | -0.20 | 0.00 | -0.04 |
| Cash from Investing Activity | -1.21 | -0.88 | -0.65 | -0.51 | 0.09 | 0.05 | 0.08 | -0.01 | -0.03 | 0.09 | 0.02 | 0.02 |
| Cash from Financing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | -0.05 | 0.14 | 0.09 | -0.09 | 0.02 | 0.04 | -0.03 | 0.04 | -0.13 | -0.11 | 0.02 | -0.02 |
| Free Cash Flow | -0.35 | 0.12 | -0.04 | -0.03 | -0.07 | -0.01 | -0.11 | 0.03 | -0.10 | -0.16 | 0.00 | -0.04 |
| CFO/OP | 109% | 37% | 68% | 45% | -3% | -6% | -19% | 15% | -77% | 76% | 0% | 10% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44.48 | 27.64 | 23.08 | 32.53 | 35.36 | 2,029.76 | 137.74 | 83.55 | 235.73 | 1,318.06 | ||
| Inventory Days | 120.15 | 57.31 | 21.38 | 25.65 | 24.45 | 542.57 | 1,460.00 | 0.00 | ||||
| Days Payable | 0.41 | 2.87 | 1.22 | 1.59 | 0.99 | 0.00 | 0.00 | |||||
| Cash Conversion Cycle | 164.22 | 82.07 | 43.23 | 56.59 | 58.82 | 2,029.76 | 137.74 | 83.55 | 778.30 | 2,778.06 | ||
| Working Capital Days | 146.47 | 77.30 | 41.27 | 53.68 | 56.07 | 3,191.52 | 27.55 | -65.96 | 562.71 | 3,183.61 | ||
| ROCE % | 6.63% | 21.46% | 5.41% | 4.50% | 4.01% | 0.37% | 0.63% | 0.63% | 7.98% | -2.45% | -27.01% | -6.23% |
| Jun 2016 | Sep 2016 | Dec 2016 | |
|---|---|---|---|
| Promoters | 32.04% | 32.04% | 32.04% |
| Public | 67.96% | 67.96% | 67.96% |
| No. of Shareholders | 12,433 | 12,373 | 12,139 |
Fundamentals
Market Cap₹ 5.17 Cr.
Current Price₹ 0.47
Book Value₹ 0.52
ROCE-6.23 %
ROE-6.23 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)82%
Standalone figures.
Valuation
P/B, 3-year average0.74x
P/E, 5-year average36.66x
P/B, 5-year average0.59x
Profitability
EBITDA margin-74.74%
Pre-tax margin-88.42%
Net profit margin4.21%
Net margin, latest quarter5.00%
ROE-13.77%
ROCE-13.77%
ROA-12.44%
ROE, 3-year average-24.98%
ROCE, 3-year average-25.25%
ROA, 3-year average-23.44%
ROE, 5-year average-13.47%
ROCE, 5-year average-13.43%
ROA, 5-year average-12.58%
ROIC (approx.)-14.81%
Other income / net worth-7.75%
Growth
Sales growth QoQ-42.86%
Profit growth QoQ0.00%
Sales growth YoY (latest quarter)-9.09%
Profit growth YoY (latest quarter)-80.00%
Per share
EPS (TTM)Rs 0.00
EPS (latest year)Rs -0.08
EPS (latest quarter)Rs 0.00
EPS, 3-year averageRs -0.19
EPS, 5-year averageRs -0.10
Book value per shareRs 0.52
Sales per shareRs 0.09
Cash flow per shareRs -0.00
Free cash flow per shareRs -0.00
Efficiency
Creditor days0 days
Cash conversion cycle2778 days
Working capital days3184 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Owners' fund to total sources95.14%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -0 Cr
Statement figures
Net sales (TTM)Rs 1 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs -0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -1 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs -1 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs -0 Cr
Share capitalRs 11 Cr
ReservesRs -5 Cr
Shareholders' fundsRs 6 Cr
Total assetsRs 6 Cr
Net blockRs 4 Cr
InvestmentsRs 2 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)10.99
Ownership
Promoter holding32.04%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 4 of 6| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Dec 2016Sales ₹0 Cr -9.1% vs Dec 2015.
Net profit ₹0 Cr -80.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Anthem Biosciences Ltd | 48,996 | 82.6 | 30.4 % |
| Advanced Enzyme Technologies Ltd | 3,152 | 20.0 | 14.0 % |
| CCME Global Ltd | 208 | -2.92 % | |
| Vivo Bio Tech Ltd | 36 | 7.74 % | |
| Shree Ganesh Biotech India Ltd | 19 | 1.31 % | |
| Genomic Valley Biotech Ltd | 9 | 886 | 1.02 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Mavens Biotech Ltd?
Mavens Biotech Ltd (590083) has a market capitalisation of Rs 5.17 Cr. at the close.
What were Mavens Biotech Ltd's latest quarterly results?
In the Dec 2016 quarter, Mavens Biotech Ltd sales was Rs 0 Cr (-9.1% vs Dec 2015) and net profit was Rs 0 Cr.